Eagle Meds Services
Pristiq (desvenlafaxine) product image
Available to sourceHuman Prescription DrugNeurological & Psychiatric

Pristiq (desvenlafaxine succinate)

50 mg/1 · Extended-Release Tablet
By Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.
NDC
0008-1211
Route
Oral
Therapeutic class
Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor
Marketing category
NDA

Package sizes

  • 14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-14)NDC 0008-1211-14Available to order
  • 30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-30)NDC 0008-1211-30Available to order
  • 90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1211-01)NDC 0008-1211-01Available to order
  • 100 BLISTER PACK in 1 CARTON (0008-1211-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACKNDC 0008-1211-50Available to order

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
Pristiq (desvenlafaxine succinate)
NDC 0008-1211